<html>
<head>PUBMED IDs for DNASE1L3</head>
<body bgcolor='#C5F0F2'><h1>DNASE1L3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/21692081/'>Global genetic analysis of all single nucleotide polymorphisms in exons of the human deoxyribonuclease I-like 3 gene and their effect on its catalytic activity.</a> September 9  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22019780/'>Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus.</a> January 21  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/23666765/'>DNASE1L3 mutations in hypocomplementemic urticarial vasculitis syndrome.</a> October 18  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24206041/'>Evaluation of all non-synonymous single nucleotide polymorphisms (SNPs) in the genes encoding human deoxyribonuclease I and I-like 3 as a functional SNP potentially implicated in autoimmunity.</a> March 5  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24387989/'>Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis.</a> February 25  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24587967/'>Eradication of Human Ovarian Cancer Cells by Transgenic Expression of Recombinant DNASE1, DNASE1L3, DNASE2, and DFFB Controlled by EGFR Promoter: Novel Strategy for Targeted Therapy of Cancer.</a> March 4  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25332064/'>An Immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3.</a> August 5  2014<br></body></html>
